Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1111/sji.12937

http://scihub22266oqcxt.onion/10.1111/sji.12937
suck pdf from google scholar
32657436!7404338!32657436
unlimited free pdf from europmc32657436    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32657436  :  Publisher
PDF vom PMID32657436

suck abstract from ncbi

pmid32657436
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Can medicinal mushrooms have prophylactic or therapeutic effect against COVID-19 and its pneumonic superinfection and complicating inflammation? #MMPMID32657436
  • Hetland G; Johnson E; Bernardshaw SV; Grinde B
  • Scand J Immunol 2021[Jan]; 93 (1): e12937 PMID32657436show ga
  • Medicinal mushrooms have documented effects against different diseases, including infections and inflammatory disorders. The related Basidiomycota Agaricus blazei Murill (AbM), Hericium erinaceus (HE), and Grifola frondosa (GF) have been shown to exert antimicrobial activity against viral agents, Gram-positive and Gram-negative bacteria, and parasites in vitro and in vivo. Since the mechanism is immunomodulatory and not antibiotical, the mushrooms should be active against multi-drug resistant microbes as well. Moreover, since these Basidiomycota also have anti-inflammatory properties, they may be suited for treatment of the severe lung inflammation that often follows COVID-19 infection. An AbM-based mushroom extract (Andosan), also containing HE and GF, has been shown to significantly reduce bacteraemia and increase survival in mice with pneumococcal sepsis, and to improve symptoms and quality of life in IBD patients via an anti-inflammatory effect. Hence, such mushroom extracts could have prophylactic or therapeutic effect against the pneumonic superinfection and severe lung inflammation that often complicates COVID-19 infection. Here, we review antimicrobial and anti-inflammatory properties of AbM, HE and GF mushrooms, which could be used for the battle against COVID-19.
  • |*Agaricales[MESH]
  • |*SARS-CoV-2[MESH]
  • |Anti-Infective Agents/*therapeutic use[MESH]
  • |Anti-Inflammatory Agents/*therapeutic use[MESH]
  • |COVID-19/complications/*prevention & control/therapy[MESH]
  • |Humans[MESH]
  • |Immunologic Factors/pharmacology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    e12937 1.93 2021